The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX)

被引：35
|
作者：
Giverhaug, T [1 ]
Loennechen, T
Aarbakke, J
机构：
[1] Univ Tromso, Inst Pharm, Dept Pharmacol, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway
来源：
GENERAL PHARMACOLOGY | 1999年 / 33卷 / 04期
关键词：
6-mercaptopurine; methotrexate; interaction;
D O I：
10.1016/S0306-3623(99)00022-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The antimetabolites 6-mercaptopurine (6-MP) and metliotrexate (MTX) are the cornerstones in the maintenance treatment of children's acute lymphoblastic leukemia (ALL). The biochemical mechanisms underlying the increased therapeutic efficacy of the combination of these drugs have not yet been elucidated. However, both drugs interact with important pathways, such as purine de novo synthesis (PDNS), purine salvage, and methylation reactions. A review of the mechanistic aspects of the interactions between 6-MP and MTX is given. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码：341 / 346
页数：6
相关论文
共 50 条
  • [21] The absorption of 6-mercaptopurine from 6-mercaptopurine riboside in rat small intestine: Effect of phosphate
    Pennington, AM
    Bronk, JR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (02) : 136 - 142
  • [22] Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate
    Ogungbenro, Kayode
    Aarons, Leon
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (02) : 159 - 171
  • [23] Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate
    Kayode Ogungbenro
    Leon Aarons
    Journal of Pharmacokinetics and Pharmacodynamics, 2014, 41 : 159 - 171
  • [24] 6-Mercaptopurine and inflammatory bowel disease
    Madrigal, EJD
    Garcia, LY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (06) : 455 - 456
  • [25] Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency
    Andersen, JB
    Szumlanski, C
    Weinshilboum, RM
    Schmiegelow, K
    ACTA PAEDIATRICA, 1998, 87 (01) : 108 - 111
  • [26] Effect of 6-mercaptopurine on rat placenta
    Furukawa, Satoshi
    Usuda, Koji
    Abe, Masayoshi
    Hayashi, Seigo
    Ogawa, Izumi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2008, 70 (06) : 551 - 556
  • [27] CHEMILUMINESCENCE DETERMINATION OF 6-MERCAPTOPURINE IN PHARMACEUTICALS
    HE, ZK
    LIU, XL
    LUO, QY
    YU, XM
    ZENG, Y
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 1995, 11 (03): : 266 - 270
  • [28] THE CLINICAL-PHARMACOLOGY OF 6-MERCAPTOPURINE
    LENNARD, L
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) : 329 - 339
  • [29] IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases
    Meuwissen, SGM
    Ewe, K
    Gassull, MA
    Geboes, K
    Jewell, D
    Pallone, F
    Rachmilewitz, D
    Rask-Madsen, J
    Riddell, BH
    Sandborn, BJ
    Schmuck, ML
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (01) : 13 - 18
  • [30] The effectiveness of L-Carnitine on improving liver enzymes in Leukemic patients treated with Methotrexate and 6-Mercaptopurine
    Golpaygani, Mohammad Reza
    Pourazar, Elham
    Yousefi, Gholamreza
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2021, 9 (09): : 14348 - 14354
12345